Parker Waichman LLP Headlines by Topic
Avandia Heart Attack
FDA identifies stumbling blocks for new diabetes drug
Jan 9, 2013
The Food and Drug Administration issued a statement this week indicating that a clinical trial of a new type 2 diabetes drug has suffered some...
Glaxo Reaches Record $3 Billion Settlement to Resolve Paxil, Wellbutrin and Avandia Fraud Charges
Jul 3, 2012
| Parker Waichman LLP
GlaxoSmithKline has agreed to pay a record settlement to resolve charges that it illegally marketed some of its drugs, including Paxil and...
Diabetic Macular Edema a Possible Avandia, Actos Side Effect
Jun 12, 2012
| Parker Waichman LLP
A new study is raising more concerns about the possible side effects of thiazolidinediones, a group of drugs that includes Actos and...
Settlements Reported in 20,000 Avandia Heart Attack Lawwsuits
Feb 2, 2012
| Parker Waichman LLP
GlaxoSmithKline has reportedly agreed to settle more than 20,000 Avandia heart attack lawsuits, according to a report from Bloomberg News. The...
Avandia, Actos Study Sees Higher Risk of Diabetic Macular Edema
Jun 28, 2011
| Parker Waichman LLP
People taking the diabetes medications Actos or Avandia have yet another side effect to worry about - a potentially blinding eye disorder called...
1,000 Avandia Settlements in the Works
May 5, 2011
| Parker Waichman LLP
Momentum appears to be building towards more Avandia lawsuit settlements. Bloomberg News is reporting that GlaxoSmithKline, maker of the...
Page 1/1
ParkerWaichmanLLP
@ParkerWaichman
parkerwaichman
parkerwaichmanllp